TrialHIV clinical trials

Baseline CD4+ T-cell counts predict HBV viral kinetics to adefovir treatment in lamivudine-resistant HBV-infected patients with or without HIV infection.

K J Cortez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.